Erik C. Emerson - Insider Trading & Ownership

Location: 2300 West Sahara Avenue, Suite 800 #4012, Las Vegas, NV
Summary: The estimated net worth of Erik C. Emerson is at least $1.32M dollars as of October 17, 2025. Erik C. Emerson is the Chief Executive Officer, Director of Apimeds Pharmaceuticals US, Inc. and owns shares of Apimeds Pharmaceuticals US, Inc. (APUS) stock worth about $1.31M. Erik C. Emerson is the Chief Commerical Officer of Odyssey Health, Inc. and owns shares of Odyssey Health, Inc. (ODYY) stock worth about $3.19K.
Signature: /s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Erik C. Emerson files a new Insider Trading report.

Ownership of Erik C. Emerson

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
APUS	Apimeds Pharmaceuticals US, Inc.	Chief Executive Officer, Director	$1.31M			Oct 15, 2025
ODYY	Odyssey Health, Inc.	Chief Commerical Officer	$3.19K			Jan 16, 2024

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.